Glaxo Agrees to Pay $3 Billion in Fraud Settlement
By: Carrie Johnson
July 2, 2012
British pharmaceutical giant GlaxoSmithKline has agreed to pay $3 billion in civil and criminal fines for promoting two drugs, Paxil and Wellbutrin, for unapproved uses, and failing to report key safety data about the diabetes drug Avandia.
When you give to WAMU, your tax-deductible membership gift helps make possible award-winning programs such as Morning Edition, All Things Considered, The Diane Rehm Show, The Kojo Nnamdi Show, and other favorites.